Yaseen M, Salacinski H J, Seifalian A M, Lu J R
Biological Physics Group, School of Physics and Astronomy, University of Manchester, UK.
Biomed Mater. 2008 Sep;3(3):034123. doi: 10.1088/1748-6041/3/3/034123. Epub 2008 Sep 3.
Polyurethanes (PU) and their polymeric derivatives are widely used in the manufacturing of medical devices. It is important to understand how protein adsorbs onto PU materials as this molecular process directly implicates surface biocompatibility. In this work, we compared protein adsorption at the PU film surfaces with that from the hydrophilic silicon oxide. Two PU polymers were used, a commercial polyurethane (PUA) and a novel poly(carbonate-urea)urethane matrix containing silsesquioxanes (PU4). AFM imaging revealed micro-domain segregation on both PU surfaces, but the incorporation of pendent silsesquioxanes made the PU4 surface much rougher, with the outer surface comprised of soft upper PU segments and lower PU-silsesquioxane hard segments. It appeared that fibrinogen was preferable to adsorb onto the upper soft PU segments. The spectroscopic ellipsometry (SE) measurements at the PU film/solution interface showed that human serum albumin (HSA) adsorption was little affected by surface chemistry whilst fibrinogen adsorption was much greater on the two PU surfaces indicating a strong surface effect. Further studies revealed that HSA adsorption was reversible on hydrophilic SiO(2) against changes in pH from 5 to 7, but irreversible on the two PU surfaces. In contrast, fibrinogen adsorption against the same pH cycling was found to be irreversible on all three surfaces. The different extent of irreversibility was clearly indicative of different interfacial interactions. Sequential protein adsorption revealed that the PU4 surface shared similar physiochemical properties to the SiO(2) surface, demonstrating the success in incorporating the siloxane pendant nanocages. The knowledge of protein surface structure and behaviour may lead to the development of effective means to control surface biocompatibility.
聚氨酯(PU)及其聚合物衍生物广泛应用于医疗器械制造。了解蛋白质如何吸附到PU材料上非常重要,因为这个分子过程直接涉及表面生物相容性。在这项工作中,我们比较了蛋白质在PU膜表面和在亲水性氧化硅表面的吸附情况。使用了两种PU聚合物,一种是商业聚氨酯(PUA),另一种是含有倍半硅氧烷的新型聚(碳酸酯 - 脲)聚氨酯基质(PU4)。原子力显微镜成像显示两个PU表面都存在微区偏析,但引入的倍半硅氧烷基团使PU4表面更加粗糙,其外表面由柔软的上层PU链段和下层PU - 倍半硅氧烷硬链段组成。似乎纤维蛋白原更倾向于吸附在上层柔软的PU链段上。在PU膜/溶液界面进行的光谱椭偏测量(SE)表明,人血清白蛋白(HSA)的吸附受表面化学影响较小,而纤维蛋白原在两个PU表面的吸附量要大得多,表明存在强烈的表面效应。进一步研究表明,在pH值从5到7变化时,HSA在亲水性SiO₂ 上的吸附是可逆的,但在两个PU表面上是不可逆的。相比之下,在相同的pH循环下,纤维蛋白原在所有三个表面上的吸附都是不可逆的。不同程度的不可逆性清楚地表明了不同的界面相互作用。顺序蛋白质吸附表明,PU4表面与SiO₂ 表面具有相似的物理化学性质,这证明了引入硅氧烷基团悬挂纳米笼的成功。对蛋白质表面结构和行为的了解可能会导致开发出控制表面生物相容性的有效方法。